Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ...
The MPS I genetic defect attacks body and mind, but early diagnosis can prevent worse - Austria is lagging behind, much to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback